Bristol-Myers Squibb Target, Estimates Under Review At Goldman Sachs
April 28, 2016 at 13:05 PM EDT
Bristol-Myers Squibb Co (NYSE: BMY) reported strong 1Q results, while raising its guidance for 2016. 1Q Beat Goldman Sachs’ Jami ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.